Related Experiment Videos

Doing better with cancer in adolescents and young adults

Catherine H Cole

    The Medical Journal of Australia
    |January 16, 2004
    PubMed

    Insights

    Adolescents and young adults with serious illnesses experience poorer outcomes compared to children. They also face significant barriers in accessing novel clinical trial therapies.

    Area of Science:

    • Pediatric Oncology
    • Clinical Trial Access
    • Adolescent Health

    Background:

    • Children with serious illnesses have established access to clinical trial therapies.
    • Adolescents and young adults (AYA) with serious illnesses have worse outcomes than pediatric patients.
    • AYA often lack equivalent access to clinical trial therapies compared to children.

    Discussion:

    • The disparity in clinical trial access for AYA suggests a critical gap in equitable healthcare.
    • Investigating the reasons behind this access gap is crucial for improving AYA health outcomes.
    • Current pediatric clinical trial frameworks may not adequately serve the unique needs of AYA.

    Key Insights:

    • Adolescents and young adults demonstrate inferior outcomes relative to pediatric populations.
    • A significant disparity exists in clinical trial therapy access between children and AYA.
    • This inequity highlights a pressing need for improved AYA-specific clinical research participation.

    Outlook:

    • Future research should focus on understanding and mitigating barriers to AYA clinical trial enrollment.
    • Developing AYA-tailored clinical trial designs and access strategies is essential.
    • Enhancing clinical trial access for AYA could significantly improve their long-term health and survival rates.

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    Cancer Prevention02:59

    Cancer Prevention

    Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
    Some...